Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

NCT06578741 is registered in ClinicalTrials.gov with W.L.Gore & Associates as lead sponsor.

NCT NCT06578741
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06578741 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study
Lead sponsor
W.L.Gore & Associates
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 25, 2024
Completion date
June 1, 2036
Enrollment
310 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm, pararenal aortic aneurysm, thoracoabdominal aortic aneurysm